Sort   by:  
 Page size 
UnknownAn Immune-Related Genetic Feature Depicted the Heterogeneous Nature of Lung Adenocarcinoma and Squamous Cell Carcinoma and Their Distinctive Predicted Drug Responses.
Not available
S-EPMC9442502 | biostudies-literature
UnknownA middle lobe sparing sleeve resection versus bilobectomy for right lower central non-small cell lung cancer: a retrospective propensity score matched cohort study
Not available
S-EPMC11020639 | biostudies-literature
UnknownRadiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis.
Not available
S-EPMC4924363 | biostudies-literature
UnknownG9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.
Not available
S-EPMC5477595 | biostudies-literature
UnknownEfficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer.
Not available
S-EPMC11787076 | biostudies-literature
UnknownN6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.
Not available
S-EPMC8377850 | biostudies-literature
UnknownOptimal surgical timing for lung cancer following SARS-CoV-2 infection: a prospective multicenter cohort study.
Not available
S-EPMC11465869 | biostudies-literature
ProteomicsIntegrative analysis of proteome and ubiquitylome reveals unique features of protein ubiquitylation and mitochondria in gefitinib resistant non-small cell lung cancer cells
Even though gefitinib, a tyrosine kinase inhibitor, widely used in treating non-small cell lung cancer (NSCLC) patients carrying EGFR activating mutations, most patients will develop gefitinib resistance. Protein ubiquitylation is one of major posttranslational modifications affecting the stab...
ORGANISM(S): Homo sapiens (Human) 
2018-07-05 | PXD004941 | Pride
Human Lc_msms Lung Non-small cell lung cancer cells 
UnknownHypermetabolic pulmonary lesions detection and diagnosis based on PET/CT imaging and deep learning models.
Not available
S-EPMC12316760 | biostudies-literature
UnknownOn-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Not available
S-EPMC8722280 | biostudies-literature
Sort   by:  
 Page size